AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, As Monotherapy and in Combination with Abiraterone Acetate Plus Prednisone (AAP), in Patients (pts) with Metastatic Castrate-Resistant Prostate Cancer (Mcrpc).
Annals of Oncology(2018)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined